1-2 of 2
Carlo Gambacorti-Passerini
Close
Sort by
Journal Articles

A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK + lymphomas

Giovanni Rindone, Andrea Aroldi, Elisa Bossi, Luisa Verga, Giovanni Zambrotta, Sara Tarantino, Rocco Piazza, Lara Mussolin, Roberto Chiarle, Carlo Gambacorti-Passerini
Journal: Blood Advances
Blood Adv (2023) 7 (3): 314–316.
https://doi.org/10.1182/bloodadvances.2022007538
Published: 2023
Includes: Supplemental data
Journal Articles

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study

Clinical Trials & Observations
Carlo Visco, Luigi Marcheselli, Roberto Mina, Marianna Sassone, Anna Guidetti, Domenico Penna, Chiara Cattaneo, Valentina Bonuomo, Alessandro Busca, Andrés José María Ferreri, Riccardo Bruna, Luigi Petrucci, Roberto Cairoli, Marco Salvini, Lorenza Bertù, Marco Ladetto, Sofia Pilerci, Antonello Pinto, Safaa Ramadan, Francesco Marchesi, Michele Cavo, Luca Arcaini, Elisa Coviello, Alessandra Romano, Pellegrino Musto, Massimo Massaia, Nicola Fracchiolla, Monia Marchetti, Annamaria Scattolin, Maria Chiara Tisi, Antonio Cuneo, Matteo Della Porta, Livio Trentin, Marco Turrini, Filippo Gherlinzoni, Agostino Tafuri, Sara Galimberti, Monica Bocchia, Valeria Cardinali, Daniela Cilloni, Alessandro Corso, Daniele Armiento, Luigi Rigacci, Elettra Ortu La Barbera, Carlo Gambacorti-Passerini, Giuseppe Visani, Daniele Vallisa, Adriano Venditti, Carmine Selleri, Annarita Conconi, Patrizia Tosi, Francesco Lanza, Anna Candoni, Mauro Krampera, Paolo Corradini, Francesco Passamonti, Francesco Merli, on behalf of the ITA-HEMA-COV investigators
Journal: Blood Advances
Blood Adv (2022) 6 (1): 327–338.
https://doi.org/10.1182/bloodadvances.2021005691
Published: 2022
Includes: Supplemental data